Review article · 25 Sep 2021
Short communicationPublished 24 Mar 2022
Ivermectin Use In Covid19 Prophylaxis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Ivermectin is a safe, non-expensive and available drug. It has been previously approved by US FDA as a well-tolerable safe drug used previously for treatment and even mass prophylaxis of several parasitic drugs. It has been investigated in the current pandemic and proved a high effectiveness for chemoprophylaxis against SARS-CoV-2. Use of ivermectin can provide temporary protection that is not long-term immunity as occurs with a vaccine. Therefore, its use may be repeated. Ivermectin could be one of the hopes for ending the current dilemma of SARS-CoV-2 pandemic if used properly under medical supervision. It can be used for mass prophylaxis of the whole population at the same time especially for poor and middle-income countries that do not have the facilities to deliver good effective vaccines. Otherwise, it can be used as an emergency in case of exposure or contact with the patient and even used at the onset of infection. However, it may not be useful in treating severe cases because the virus can cause many organs to fail. We recommend further studies to confirm the effectiveness of ivermectin in preventing COVID- 19 rather than dismiss it on the basis of insufficient evidence. Studying is very easy, does not take much time and does not cause economic or health burden. This also does not require special equipment or abilities except for volunteers to join through the investigation.
Keywords
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 23 Aug 2021
Ivermectin in Covid-19: Important and Timely Updates for Family Medicine Physicians
Research article · 21 May 2021
In Search for the Truth about Hydroxychloroquine Prophylaxis of Covid-19
Research article · 30 Mar 2021
Can Hydroxychloroquine Prophylaxis be Useful among Health Care Workers in Prevention of COVID-19?
Commentary · 20 Jun 2024
Populism and Ivermectin: Comments on the Report of the Independent Commission of Investigation on the COVID-19 Pandemic in Mexico
More from this journal
The newest in Journal of Clinical Case Reports.
Brief report · 30 Mar 2026
Electrolyte Imbalances Cause Severe Cardiac Arrhythmias
Opinion · 30 Mar 2026
Atypical Multiple Sclerosis in Young Adults: Challenges and Management
Brief report · 30 Mar 2026
Stress-Induced Heart Failure: The Mind-Heart Connection
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Case Reports
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Prof. Abdelmonem Awad Hegazy”

